Provider profile · Multiple program options

Noom Med review: services, costs, and questions

Noom's behavioral and medical weight-management offerings, changing program options, and how to evaluate microdosing claims.

Sources checked · Official page retrieved · Medical review pending

A teal laptop, a burgundy folder, a blank receipt, and an envelope on a desk.
Care and costs, illustrated. This is not a photograph of a listed provider or service.
Evidence boundary: This is a review of public information, not a hands-on treatment assessment. We have not independently audited pharmacies, clinician credentials, response times, or patient outcomes. We do not assign a star rating.

What the official information says

Noom's official Med page describes medication-related weight-management care alongside its behavioral program. Research surfaced more than one program, including offers described as microdose GLP-1 care.

A program label does not identify the medicine, route, dose, or evidence. Ask whether the proposed prescription is FDA-approved for the intended use, and whether a microdosing regimen differs from the approved label.

Sources: Noom Med official program page

Pricing and the full bill

Noom advertises different introductory and recurring program prices across its program pages. This profile does not combine them into a single maintenance price. Get a quote for the exact program, clinical services, medication, and subscription duration; a behavioral subscription may not include the pharmacy bill.

A first-month price is not a reliable annual budget. Ask for the amount charged today, the renewal interval, the cost after any promotion, and whether medication, supplies, visits, labs, and shipping are included. Obtain cancellation and refund terms before paying, particularly if a prescription has not yet been approved.

Sources: Noom Med official program page

Limitations that affect your decision

Microdosing language does not establish that a regimen produces approved-dose weight-loss or prevention benefits. A clinician should explain the rationale and the supporting evidence for the actual medicine and dose.

Behavioral support may be useful to evaluate separately from medication sourcing. We have not measured support quality, app adherence, or outcomes for Noom's enrolled population.

Medication trials evaluate specific formulations, doses, and study populations. A provider advertising semaglutide or tirzepatide has not thereby demonstrated that its own treatment produces the results of Wegovy or Zepbound trials. A compounded medicine is not FDA-approved and should not be described as an approved generic equivalent.

Sources: FDA concerns with unapproved GLP-1 drugs used for weight loss · FDA clarification of compounding policies as GLP-1 supply stabilizes

Questions to ask before enrollment

  • What does microdose mean for the actual medicine, and which outcomes have been studied at that dose?
  • Which subscription and pharmacy charges continue after the introductory period?
  • What exact medicine, formulation, and device would I receive, and which pharmacy dispenses it?
  • Who prescribes in my state, and how do I obtain urgent clinical help?
  • What will I pay at maintenance, and when do renewals and cancellation deadlines occur?

Ask the prescribing clinician how your other medicines, diabetes treatment, pregnancy plans, gastrointestinal history, and follow-up needs affect eligibility. Check the dispensing pharmacy with the relevant state board. A reassuring website or testimonial does not replace those checks.

Sources: FDA concerns with unapproved GLP-1 drugs used for weight loss